4
Changes in Ownership
ACADIA PHARMACEUTICALS INC Filed Acc 0001209191-23-056354
Principal Accounting Officer sold 1,985 shares at $22.64 ($44,940)
- Principal Accounting Officer acquired 3,964 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Kihara James Principal Accounting Officer | 2023-11-17 | Option exercise | +1,982 | 13,028 | D: show line 1 in the form | ||
| Kihara James Principal Accounting Officer | 2023-11-17 | Option exercise | +1,982 | 15,010 | D: show line 2 in the form | ||
| Kihara James Principal Accounting Officer | 2023-11-20 | Sale | −1,985 | $22.64 | $44,940 | 13,025 | D: show line 3 in the form |
| Open-market sales · 1,985 sh · avg $22.64 · $44,940 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Kihara James Principal Accounting Officer | 2023-11-17 | Option exercise · Restricted Stock Units | −1,982 | 7,931 | D: show line 4 in the form | ||
| Kihara James Principal Accounting Officer | 2023-11-17 | Option exercise · Restricted Stock Units | −1,982 | 7,931 | D: show line 5 in the form |
Loading xslF345X05/doc4.xml…